|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013.
ABBV $79.76 -1.48 (-1.82%)
Sector Health Care
Industry Biotech & Pharma
Market Cap 119.84 Billion
EPS -1.14 P/E Ratio 21.79
Previous Earnings Fri, Nov 2, 2018
Latest Earnings Fri, Jan 25, 2019
Dividend 5.37% / $4.28
Ex-Date Fri, Apr 12, 2019
Dividend Pay Date Wed, May 15, 2019
Dividend History 26 Payments (Quarterly)
Investing Quotes #Legendary
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.